Rocket Pharmaceuticals Warrant
RCKTW
13 hedge funds and large institutions have $349K invested in Rocket Pharmaceuticals Warrant in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 0 closing their positions.
30% more funds holding
Funds holding: 10 → 13 (+3)
0.23% less ownership
Funds ownership: 2.35% → 2.12% (-0.23%)
35% less capital invested
Capital invested by funds: $538K → $349K (-$189K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$7.8K |
| 2 |
VF
Virtu Financial
New York
|
+$1.21K |
| 3 |
CS
Clear Street
New York
|
+$7 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$1.32K |
| 2 |
Walleye Capital
New York
|
-$375 |
RCKTW Hedge Fund Activity: Q1 2025 in Review
13 of the 7,471 institutional investors tracked by Wall St. Rank reported a position in Rocket Pharmaceuticals Warrant (RCKTW) for Q1 2025, worth a combined $349K — down 35% from $538K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new RCKTW positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $7.8K. The largest seller was Citadel Advisors, cutting an estimated $1.32K.
- 13 institutional investors held Rocket Pharmaceuticals Warrant (RCKTW) as of Q1 2025, up from 10 in Q4 2024.
- Funds reported $349K of Rocket Pharmaceuticals Warrant stock for Q1 2025, down 35% quarter-over-quarter.
- 3 funds opened new Rocket Pharmaceuticals Warrant positions in Q1 2025 and 0 closed out, a net change of +3 holders.
- The largest Rocket Pharmaceuticals Warrant buyer in Q1 2025 was Susquehanna International Group, an estimated $7.8K added.
- The largest Rocket Pharmaceuticals Warrant seller in Q1 2025 was Citadel Advisors, an estimated $1.32K sold.
Based on aggregated 13F filings for Q1 2025.